We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Mereo Biopharma Group Plc | LSE:MPH | London | Ordinary Share | GB00BZ4G2K23 | ORD GBP0.003 (REG S) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 26.50 | 26.00 | 27.00 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:9732Q Marchpole Holdings PLC 16 October 2003 For immediate release 16 October 2003 Marchpole Holdings PLC (the "Company") Capital reduction approval On 3 October 2003 Marchpole Holdings PLC announced that a hearing was due to be held on 15 October 2003 at which the High Court would consider the proposed reduction of share capital of the Company and of amounts standing to the Company's share premium account which shareholders approved on 1 September 2003. The hearing took place on 15 October and the High Court approved the proposals. The reduction comprises a reduction of #22,696,368.11 by means of the cancellation of the entire class of 2,269,636,811 deferred shares of 1p each and the reduction of amounts standing to the Company's share premium account by #14,070,000. The number of ordinary shares in issue and the amount paid up on each such share will not be affected by the proposed reduction. Enquiries: Justin Hampshire, Marchpole Holdings 020 7908 7777 Simon Edwards, Shore Capital 020 7408 4090 This information is provided by RNS The company news service from the London Stock Exchange END CARMFBBTMMJBBTJ
1 Year Mereo Biopharma Chart |
1 Month Mereo Biopharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions